Carboquone: Difference between revisions

{{Short description|Chemical compound}}

{{Drugbox

| Watchedfields = changed

| verifiedrevid = 444188235

| IUPAC_name = {2-[2,5-''bis''(aziridin-1-yl)-4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl]-2-methoxyethyl} carbamate

| image = Carboquone.png

<!--Clinical data-->

| tradename =

| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->

| pregnancy_US = <!-- A / B / C / D / X -->

| pregnancy_category =

| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->

| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->

| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->

| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->

| legal_status =

| routes_of_administration =

<!--Pharmacokinetic data-->

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

<!--Identifiers-->

| CAS_number = 24279-91-2

| ATC_prefix = L01

| ATC_suffix = AC03

| PubChem = 2569

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| ChEMBL = 443014

| ChemSpiderID = 2471

| smiles = O=C(OCC(OC)C=1C(=O)\C(=C(/C(=O)C=1N2CC2)C)N3CC3)N

| StdInChI = 1S/C15H19N3O5/c1-8-11(17-3-4-17)14(20)10(9(22-2)7-23-15(16)21)12(13(8)19)18-5-6-18/h9H,3-7H2,1-2H3,(H2,16,21)

| StdInChIKey = SHHKQEUPHAENFK-UHFFFAOYSA-N

<!--Chemical data-->

| C=15 | H=19 | N=3 | O=5

'''Carboquone''' is a [[Drug#Medication|drug]] used in [[chemotherapy]].<ref>{{cite journal | vauthors = Saito T | title = [An anticancer drug--carboquone] | language = Japanese | journal = Gan to Kagaku Ryoho. Cancer & Chemotherapy | volume = 15 | issue = 3 | pages = 549–54 | date = March 1988 | pmid = 3279914 | trans-title = An anticancer drug--carboquone }}</ref>

== References ==

{{reflist}}

== See also ==

*[[Chemotherapy]]

*[[Aziridine]]

[[Category:1,4-Benzoquinones]]